Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Urology
General Rheumatology
Questions discussed in this category
How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?
Assuming no symptoms of TB, should patients be treated for latent TB prior to starting TNF inhibitors or other immunosuppressive agents?
1 Answer available
18253
Related Topics in Urology
Genitourinary Cancers
Medical Oncology
Urologic Oncology
Radiation Oncology
Bladder Cancer
Prostate Cancer
Rheumatology
General Rheumatology
Rheumatoid Arthritis
Infectious Disease